271 related articles for article (PubMed ID: 2510971)
1. Immunologic considerations for the development of conjugate vaccines.
Garner CV; Pier GB
Contrib Microbiol Immunol; 1989; 10():11-7. PubMed ID: 2510971
[No Abstract] [Full Text] [Related]
2. Contemporary trends in conjugate vaccine development.
Cruse JM; Lewis RE
Contrib Microbiol Immunol; 1989; 10():1-10. PubMed ID: 2510970
[No Abstract] [Full Text] [Related]
3. The cellular basis of the immune response to conjugate vaccines.
Bixler GS; Pillai S
Contrib Microbiol Immunol; 1989; 10():18-47. PubMed ID: 2684506
[No Abstract] [Full Text] [Related]
4. The capsular polysaccharide of group B Neisseria meningitidis as a vehicle for vaccine development.
Jennings HJ
Contrib Microbiol Immunol; 1989; 10():151-65. PubMed ID: 2479499
[No Abstract] [Full Text] [Related]
5. Background and indications for Haemophilus influenzae type b vaccines consisting of capsular antigen coupled to protein carriers.
Anderson PW; Stein EC; Insel RA
Contrib Microbiol Immunol; 1989; 10():115-24. PubMed ID: 2684504
[No Abstract] [Full Text] [Related]
6. Conjugate vaccines against Pseudomonas aeruginosa and malaria.
Cryz SJ; Sadoff JC; Que JU
Contrib Microbiol Immunol; 1989; 10():166-89. PubMed ID: 2510972
[No Abstract] [Full Text] [Related]
7. Effect of oligosaccharide chain length, exposed terminal group, and hapten loading on the antibody response of human adults and infants to vaccines consisting of Haemophilus influenzae type b capsular antigen unterminally coupled to the diphtheria protein CRM197.
Anderson PW; Pichichero ME; Stein EC; Porcelli S; Betts RF; Connuck DM; Korones D; Insel RA; Zahradnik JM; Eby R
J Immunol; 1989 Apr; 142(7):2464-8. PubMed ID: 2784464
[TBL] [Abstract][Full Text] [Related]
8. Immune response of young children vaccinated with Haemophilus influenzae type b conjugate vaccines.
Madore DV; Phipps DC; Eby R; Johnson CL; Smith DH
Contrib Microbiol Immunol; 1989; 10():125-50. PubMed ID: 2684505
[No Abstract] [Full Text] [Related]
9. [Vaccination against Haemophilus influenzae].
Huber EG
Padiatr Padol; 1991; 26(4):203-4. PubMed ID: 1749631
[No Abstract] [Full Text] [Related]
10. Advisory Committee on Immunization Practices update: report of PedvaxHIB lots with questionable immunogenicity.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1992 Nov; 41(46):878-9. PubMed ID: 1435679
[No Abstract] [Full Text] [Related]
11. Immune responses to polysaccharides: lessons from humans and mice.
González-Fernández A; Faro J; Fernández C
Vaccine; 2008 Jan; 26(3):292-300. PubMed ID: 18160186
[TBL] [Abstract][Full Text] [Related]
12. High antibody responses to booster doses of either Haemophilus influenzae capsular polysaccharide or conjugate vaccine after primary immunization with conjugate vaccines.
Käyhty H; Eskola J; Peltola H; Saarinen L; Mäkelä PH
J Infect Dis; 1992 Jun; 165 Suppl 1():S165-6. PubMed ID: 1588156
[No Abstract] [Full Text] [Related]
13. Safety and immunogenicity of a combined hepatitis B virus-Haemophilus influenzae type B vaccine formulation in healthy adults.
Bulkow LR; McMahon BJ; Wainwright RB; Parkinson AJ; Wainwright KY; House J
Arctic Med Res; 1993 Jul; 52(3):118-26. PubMed ID: 8397580
[TBL] [Abstract][Full Text] [Related]
14. Antibody responses of black children to Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer-membrane protein conjugate vaccine in relation to the Km(1) allotype.
Lenoir AA; Pandey JP; Granoff DM
J Infect Dis; 1988 Jun; 157(6):1242-5. PubMed ID: 3131441
[No Abstract] [Full Text] [Related]
15. Haemophilus influenzae type b vaccine.
Anderson P; Pichichero ME
Pediatrics; 1989 Jan; 83(1):145-6. PubMed ID: 2909967
[No Abstract] [Full Text] [Related]
16. Challenges for the development of vaccines against Haemophilus influenzae and Neisseria meningitidis.
Cripps AW; Foxwell R; Kyd J
Curr Opin Immunol; 2002 Oct; 14(5):553-7. PubMed ID: 12183152
[TBL] [Abstract][Full Text] [Related]
17. Comparative immune responses to Haemophilus influenzae type b polysaccharide and a polysaccharide-protein conjugate vaccine.
Kim KS; Wong VK; Adler R; Steinberg EA
Pediatrics; 1990 Apr; 85(4 Pt 2):648-50. PubMed ID: 2107516
[No Abstract] [Full Text] [Related]
18. Statement on Haemophilus influenzae type b conjugate vaccines for use in infants and children.
CMAJ; 1993 Jan; 148(2):199-214. PubMed ID: 8452591
[No Abstract] [Full Text] [Related]
19. A comparative study of the immune response to poly-[alpha(2-->8)-N-acetyl neuraminic acid].
Diaz Romero J; Outschoorn IM
Adv Exp Med Biol; 1995; 371A():543-8. PubMed ID: 8525985
[No Abstract] [Full Text] [Related]
20. Use of Haemophilus polysaccharide vaccine in a rural clinic setting.
Ross SA; Darby CP; Harvell J; Watson C
J S C Med Assoc; 1988 Mar; 84(3):105-8. PubMed ID: 3258942
[No Abstract] [Full Text] [Related]
[Next] [New Search]
